Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,749,419
  • Shares Outstanding, K 32,730
  • Annual Sales, $ 490,640 K
  • Annual Income, $ 81,680 K
  • 36-Month Beta 2.28
  • Price/Sales 3.55
  • Price/Cash Flow 14.97
  • Price/Book 3.68

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.05 +0.58%
on 08/10/17
62.30 -15.97%
on 08/03/17
-6.10 (-10.44%)
since 07/17/17
3-Month
51.50 +1.65%
on 05/19/17
62.30 -15.97%
on 08/03/17
-0.20 (-0.38%)
since 05/17/17
52-Week
38.30 +36.68%
on 11/03/16
62.95 -16.84%
on 05/04/17
+6.94 (+15.28%)
since 08/17/16

Most Recent Stories

More News
Cambrex Surpasses ChemStewards® Requirements and Qualifies for SOCMA's "Excellence" Ranking

Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that as a result of exceeding key performance...

CBM : 52.30 (-2.15%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (PRAH, INCR, VWR, CBM, PRXL)

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

VWR : 32.96 (-0.09%)
PRXL : 87.66 (-0.11%)
INCR : 55.47 (-0.05%)
PRAH : 75.42 (+0.35%)
CBM : 52.30 (-2.15%)
Cambrex Invests $24 Million in New Highly Potent API Manufacturing Capacity at its Charles City, Iowa Facility

Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it is to invest $24 million in a new facility...

CBM : 52.30 (-2.15%)
Cambrex to Announce Second Quarter 2017 Financial Results on August 4, 2017

Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that second quarter 2017 financial results will...

CBM : 52.30 (-2.15%)
Insys Therapeutics, Inc. Appoints Andrew G. Long as Chief Financial Officer

Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") announced today that Andrew G. Long has joined the company as Chief Financial Officer, effective August 7, 2017.

INSY : 9.32 (-1.48%)
CBM : 52.30 (-2.15%)
Zacks.com featured highlights: Hitachi, Koninklijke DSM, Embotelladora Andina, Cambrex and Ituran Location and Control

Zacks.com featured highlights: Hitachi, Koninklijke DSM, Embotelladora Andina, Cambrex and Ituran Location and Control

HTHIY : 65.8800 (-0.18%)
ITRN : 31.90 (+1.42%)
RDSMY : 18.6500 (+0.11%)
AKO.B : 27.70 (+3.90%)
CBM : 52.30 (-2.15%)
5 Top Stocks with Solid Net Profit Margin

Net profit margin is the most effective way to measure a company's profitability.

HTHIY : 65.8800 (-0.18%)
ITRN : 31.90 (+1.42%)
AKO.B : 27.70 (+3.90%)
RDSMY : 18.6500 (+0.11%)
CBM : 52.30 (-2.15%)
The Zacks Analyst Blog Highlights: Lantheus Holdings, Cambrex, Health Insurance Innovations, Anthem and American Equity Investment Life Holding

The Zacks Analyst Blog Highlights: Lantheus Holdings, Cambrex, Health Insurance Innovations, Anthem and American Equity Investment Life Holding

LNTH : 16.00 (+1.91%)
HIIQ : 33.35 (-2.77%)
ANTM : 192.33 (-0.53%)
AEL : 27.37 (-2.63%)
CBM : 52.30 (-2.15%)
Republicans Present Healthcare Bill: Top 5 Gainers

Healthcare stocks posted record highs, with hospitals and insurers climbing after Senate Republicans released a draft bill to replace Obamacare.

XPH : 40.72 (-0.54%)
LNTH : 16.00 (+1.91%)
MOH : 59.67 (+5.09%)
HCA : 77.77 (-1.54%)
AEL : 27.37 (-2.63%)
HIIQ : 33.35 (-2.77%)
ANTM : 192.33 (-0.53%)
CNC : 83.88 (+1.22%)
XBI : 75.15 (-1.75%)
THC : 12.55 (-2.86%)
CBM : 52.30 (-2.15%)
The Zacks Analyst Blog Highlights: Cambrex, Geron, Anavex Life Sciences and Histogenics

The Zacks Analyst Blog Highlights: Cambrex, Geron, Anavex Life Sciences and Histogenics

AVXL : 3.82 (-1.04%)
GERN : 2.06 (+0.98%)
HSGX : 1.76 (-1.51%)
CBM : 52.30 (-2.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance...

See More

Support & Resistance

2nd Resistance Point 54.63
1st Resistance Point 54.04
Last Price 52.30
1st Support Level 52.94
2nd Support Level 52.43

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.